LifeVantage Declares Quarterly Dividend
LifeVantage (Nasdaq:LFVN) has announced that its Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock. The dividend will be paid on December 16, 2024 to stockholders of record at the close of business on December 2, 2024. LifeVantage is a health and wellness company focusing on products that activate optimal health processes at the cellular level.
LifeVantage (Nasdaq:LFVN) ha annunciato che il suo Consiglio di Amministrazione ha approvato un dividendo in contante trimestrale di 0,04 $ per azione di azioni ordinarie. Il dividendo sarà pagato il 16 dicembre 2024 agli azionisti registrati alla chiusura delle attività del 2 dicembre 2024. LifeVantage è un'azienda nel settore della salute e del benessere che si concentra su prodotti che attivano i processi di salute ottimali a livello cellulare.
LifeVantage (Nasdaq:LFVN) ha anunciado que su Junta Directiva ha aprobado un dividendo en efectivo trimestral de 0,04 $ por acción de acciones comunes. El dividendo se pagará el 16 de diciembre de 2024 a los accionistas registrados al cierre de operaciones el 2 de diciembre de 2024. LifeVantage es una empresa de salud y bienestar que se centra en productos que activan procesos óptimos de salud a nivel celular.
라이프밴티지 (Nasdaq:LFVN)는 이사회가 보통주 1주당 0.04달러의 분기 현금 배당금을 승인했다고 발표했습니다. 이 배당금은 2024년 12월 16일에 2024년 12월 2일 업무 종료 시점에서 주주에게 지급됩니다. 라이프밴티지는 세포 수준에서 최적의 건강 과정을 활성화하는 제품에 중점을 둔 건강 및 웰빙 회사입니다.
LifeVantage (Nasdaq:LFVN) a annoncé que son Conseil d'administration a approuvé un dividende en espèces trimestriel de 0,04 $ par action ordinaire. Le dividende sera versé le 16 décembre 2024 aux actionnaires enregistrés à la clôture des affaires le 2 décembre 2024. LifeVantage est une entreprise de santé et de bien-être qui se concentre sur des produits activant des processus de santé optimale au niveau cellulaire.
LifeVantage (Nasdaq:LFVN) hat bekannt gegeben, dass der Vorstand eine vierteljährliche Barausschüttung von 0,04 $ pro Aktie der Stammaktien genehmigt hat. Die Dividende wird am 16. Dezember 2024 an die Aktionäre ausgezahlt, die am 2. Dezember 2024 zum Geschäftsschluss im Aktienregister stehen. LifeVantage ist ein Unternehmen für Gesundheit und Wellness, das sich auf Produkte konzentriert, die optimale Gesundheitsprozesse auf zellulärer Ebene aktivieren.
- Consistent dividend payment indicating financial stability
- Maintaining shareholder returns through quarterly dividend distribution
- None.
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of
About LifeVantage Corporation
LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
What is the dividend amount for LifeVantage (LFVN) in Q4 2024?
When is LifeVantage (LFVN) paying its Q4 2024 dividend?